Note: Ingredients listed on restricted chemical lists
General Information
Version
8.0
Revision date
2025-06-20
Product name
Molnupiravir Capsule Formulation
1.2.1 Relevant identified uses
Pharmaceutical
Icons in SDS
Company Information
company name
MSD
e-mail address of the competent person responsible for the Safety Data Sheet
EHSDATASTEWARD@msd.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H372
Hazard statements
Code
Statements
H372
Causes damage to organs through prolonged or repeated exposure
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture Specific target organ toxicity - repeated exposure (Oral) Category 1 (Gastrointestinal tract)
Signal word
Danger
Hazard statements
H372 Causes damage to organs (Gastrointestinal tract) through prolonged or repeated exposure if swallowed.
Prevention
P260 Do not breathe dust. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product.
Response
P314 Get medical advice/ attention if you feel unwell.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Other hazards which do not result in classification
May form explosive dust-air mixture during processing, handling or other means. Dust contact with the eyes can lead to mechanical irritation.
2.1 Classification of the substance or mixture
Specific target organ toxicity - : Category 1 (Gastrointestinal tract) repeated exposure (Oral)
